Published in J Biol Chem on December 31, 1999
OSVZ progenitors of human and ferret neocortex are epithelial-like and expand by integrin signaling. Nat Neurosci (2010) 3.21
Regulation of human neural precursor cells by laminin and integrins. J Neurosci Res (2006) 2.30
Cloning, expression, and hemostatic activities of a disintegrin, r-mojastin 1, from the mohave rattlesnake (Crotalus scutulatus scutulatus). Thromb Res (2010) 1.11
Enhanced neurite growth from mammalian neurons in three-dimensional salmon fibrin gels. Biomaterials (2007) 1.08
Trophoblast-uterine interactions at implantation. Reprod Biol Endocrinol (2004) 1.07
Sequence-specific interaction between the disintegrin domain of mouse ADAM 3 and murine eggs: role of beta1 integrin-associated proteins CD9, CD81, and CD98. Mol Biol Cell (2001) 1.05
AlphaVbeta3 integrin ligands enhance volume-sensitive calcium influx in mechanically stretched osteocytes. J Bone Miner Metab (2006) 1.04
Intravascularly administered RGD-displaying measles viruses bind to and infect neovessel endothelial cells in vivo. Mol Ther (2009) 0.97
PET Imaging of Angiogenesis. PET Clin (2009) 0.94
Integrin alphaIIbbeta3:ligand interactions are linked to binding-site remodeling. Protein Sci (2006) 0.92
Vicrostatin - an anti-invasive multi-integrin targeting chimeric disintegrin with tumor anti-angiogenic and pro-apoptotic activities. PLoS One (2010) 0.86
Anti-metastatic activity of the recombinant disintegrin, r-mojastin 1, from the Mohave rattlesnake. Toxicon (2011) 0.85
Recombinant rubistatin (r-Rub), an MVD disintegrin, inhibits cell migration and proliferation, and is a strong apoptotic inducer of the human melanoma cell line SK-Mel-28. Toxicon (2011) 0.83
Inhibition of lung tumor colonization and cell migration with the disintegrin crotatroxin 2 isolated from the venom of Crotalus atrox. Toxicon (2008) 0.83
Conformation and concerted dynamics of the integrin-binding site and the C-terminal region of echistatin revealed by homonuclear NMR. Biochem J (2005) 0.83
Inhibition of melanoma cell motility by the snake venom disintegrin eristostatin. Toxicon (2007) 0.82
Functional analysis of a recombinant PIII-SVMP, GST-acocostatin; an apoptotic inducer of HUVEC and HeLa, but not SK-Mel-28 cells. Toxicon (2011) 0.82
The mojastin mutant Moj-DM induces apoptosis of the human melanoma SK-Mel-28, but not the mutant Moj-NN nor the non-mutated recombinant Moj-WN. Toxicon (2010) 0.81
Skeletal unloading-induced insulin-like growth factor 1 (IGF-1) nonresponsiveness is not shared by platelet-derived growth factor: the selective role of integrins in IGF-1 signaling. J Bone Miner Res (2011) 0.81
Genetically modified T cells targeting neovasculature efficiently destroy tumor blood vessels, shrink established solid tumors and increase nanoparticle delivery. Int J Cancer (2013) 0.80
Development of a chimeric recombinant disintegrin as a cost-effective anti-cancer agent with promising translational potential. Toxicon (2011) 0.79
Mechanical loading promotes mast cell degranulation via RGD-integrin dependent pathways. J Biomech (2012) 0.79
Structure of acostatin, a dimeric disintegrin from Southern copperhead (Agkistrodon contortrix contortrix), at 1.7 A resolution. Acta Crystallogr D Biol Crystallogr (2008) 0.79
Effect of the disintegrin eristostatin on melanoma-natural killer cell interactions. Toxicon (2012) 0.76
Differences in binding of (99m)Tc-disintegrins to integrin alphavbeta3 on tumor and vascular cells. Nucl Med Biol (2007) 0.75
Effects of the RGD loop and C-terminus of rhodostomin on regulating integrin αIIbβ3 recognition. PLoS One (2017) 0.75
Characterization of human platelet basic protein, a precursor form of low-affinity platelet factor 4 and beta-thromboglobulin. Biochemistry (1986) 2.61
Measurement of fibrinogen and fibrin degradation products in serum by staphylococcal clumping test. J Lab Clin Med (1970) 2.21
Surface-bound heparin fails to reduce thrombin formation during clinical cardiopulmonary bypass. J Thorac Cardiovasc Surg (1996) 2.11
Laboratory identification of intravascular coagulation. The serial dilution protamine sulfate test for the detection of fibrin monomer and fibrin degradation products. J Lab Clin Med (1971) 2.04
Disintegrins: a family of integrin inhibitory proteins from viper venoms. Proc Soc Exp Biol Med (1990) 1.85
Exposure of fibrinogen receptor on human platelets by proteolytic enzymes. J Biol Chem (1981) 1.62
Studies on the adsorption and activation of the Hageman factor (factor XII) by collagen and elastin. Thromb Diath Haemorrh (1965) 1.62
Trigramin: primary structure and its inhibition of von Willebrand factor binding to glycoprotein IIb/IIIa complex on human platelets. Biochemistry (1989) 1.50
Trigramin. A low molecular weight peptide inhibiting fibrinogen interaction with platelet receptors expressed on glycoprotein IIb-IIIa complex. J Biol Chem (1987) 1.48
Release of platelet factor 4 in vivo during intravascular coagulation and in thrombotic states. Thromb Diath Haemorrh (1968) 1.41
Invited letter concerning: aprotinin. J Thorac Cardiovasc Surg (1991) 1.40
Effects of chymotrypsin and adenosine diphosphate on the exposure of fibrinogen receptors on normal human and Glanzmann's thrombasthenic platelets. J Biol Chem (1981) 1.33
Platelet interaction with polymerizing fibrin. J Clin Invest (1972) 1.31
The crystal structures of two spermadhesins reveal the CUB domain fold. Nat Struct Biol (1997) 1.28
Antiheparin proteins secreted by human platelets. purification, characterization, and radioimmunoassay. Blood (1979) 1.22
Comparison of disintegrins with limited variation in the RGD loop in their binding to purified integrins alpha IIb beta 3, alpha V beta 3 and alpha 5 beta 1 and in cell adhesion inhibition. Cell Adhes Commun (1994) 1.22
Viper venom disintegrins and related molecules. Proc Soc Exp Biol Med (1998) 1.21
Proteins secreted by the platelet. Thromb Haemost (1977) 1.20
Activation of blood clotting and inhibition of fibrinolysis in acute pancreatitis. Thromb Diath Haemorrh (1968) 1.18
Hydrodynamic liver gene transfer mechanism involves transient sinusoidal blood stasis and massive hepatocyte endocytic vesicles. Gene Ther (2005) 1.16
Subcellular localization of human platelet antiheparin proteins. Thromb Res (1979) 1.14
Neutralization of antithrombin VI (fibrinogen breakdown products) with platelet antiheparin factor (platelet factor 4). Thromb Diath Haemorrh (1965) 1.14
A comparative study of four methods for detecting fibrinogen degradation products in patients with various diseases. N Engl J Med (1970) 1.14
Platelet factor 4--antiheparin protein releasable from platelets. Purification and properties. J Lab Clin Med (1973) 1.11
Disintegrins and other naturally occurring antagonists of platelet fibrinogen receptors. Semin Hematol (1994) 1.10
The disulfide bridge pattern of snake venom disintegrins, flavoridin and echistatin. FEBS Lett (1992) 1.08
New isolation procedure and further biochemical characterization of glycoproteins IIb and IIIa from human platelet plasma membrane. Biochem J (1986) 1.07
Thrombogenic activity of mouse and human tumors: effects on platelets, coagulation, and fibrinolysis, and possible significance for metastases. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol (1976) 1.06
Inhibition of human megakaryocytopoiesis in vitro by platelet factor 4 (PF4) and a synthetic COOH-terminal PF4 peptide. J Clin Invest (1989) 1.05
Inhibition of platelet adhesion to surfaces of extracorporeal circuits by disintegrins. RGD-containing peptides from viper venoms. Circulation (1990) 1.05
Biochemistry of alpha granule proteins. Semin Hematol (1985) 1.05
The interaction of human platelet thrombospondin with fibrinogen. Thrombospondin purification and specificity of interaction. J Biol Chem (1985) 1.02
Echicetin: a snake venom protein that inhibits binding of von Willebrand factor and alboaggregins to platelet glycoprotein Ib. Blood (1993) 1.02
Platelet antiheparin proteins and antithrombin III interact with different binding sites on heparin molecule. FEBS Lett (1979) 1.01
Aprotinin inhibits the contact, neutrophil, and platelet activation systems during simulated extracorporeal perfusion. J Thorac Cardiovasc Surg (1993) 1.01
Significance of the intact polypeptide chains of human fibrinogen in ADP-induced platelet aggregation. Blood (1977) 1.01
Platelet-specific alpha-granule proteins and thrombospondin in bronchoalveolar lavage in the adult respiratory distress syndrome. Chest (1989) 1.00
Identification of the disulfide bond pattern in albolabrin, an RGD-containing peptide from the venom of Trimeresurus albolabris: significance for the expression of platelet aggregation inhibitory activity. Biochemistry (1991) 1.00
Elegantin and albolabrin purified peptides from viper venoms: homologies with the RGDS domain of fibrinogen and von Willebrand factor. Biochim Biophys Acta (1990) 1.00
Inhibitory effects of MLDG-containing heterodimeric disintegrins reveal distinct structural requirements for interaction of the integrin alpha 9beta 1 with VCAM-1, tenascin-C, and osteopontin. J Biol Chem (2000) 1.00
EC3, a novel heterodimeric disintegrin from Echis carinatus venom, inhibits alpha4 and alpha5 integrins in an RGD-independent manner. J Biol Chem (1999) 0.99
Importance of the structure of the RGD-containing loop in the disintegrins echistatin and eristostatin for recognition of alpha IIb beta 3 and alpha v beta 3 integrins. FEBS Lett (1996) 0.99
Isolation and characterization of EMS16, a C-lectin type protein from Echis multisquamatus venom, a potent and selective inhibitor of the alpha2beta1 integrin. Biochemistry (2000) 0.99
Platelet factor 4 and adenosine diphosphate release during human platelet aggregation. Nature (1969) 0.98
Iloprost and echistatin protect platelets during simulated extracorporeal circulation. Ann Thorac Surg (1995) 0.97
The crystal structure of Canavalia brasiliensis lectin suggests a correlation between its quaternary conformation and its distinct biological properties from Concanavalin A. FEBS Lett (1997) 0.97
Molecular characterization of human platelet glycoproteins IIIa and IIb and the subunits of the latter. Eur Biophys J (1987) 0.97
Antigenic and antiheparin properties of human platelet factor 4 (PF4). Blood (1975) 0.97
Fibrinogen interaction with platelet receptors. Ann N Y Acad Sci (1983) 0.97
Abnormal inside-out signal transduction-dependent activation of glycoprotein IIb-IIIa in a patient with impaired pleckstrin phosphorylation. Blood (1996) 0.96
Human platelet basic protein associated with antiheparin and mitogenic activities: purification and partial characterization. Proc Natl Acad Sci U S A (1980) 0.96
Adsorption of Hageman factor (Factor XII) on collagen. Experientia (1964) 0.96
Nonenzymatic polymerization of fibrinogen by protamine sulfate. An electron microscope study. Biochim Biophys Acta (1969) 0.96
The 2.4 A resolution crystal structure of boar seminal plasma PSP-I/PSP-II: a zona pellucida-binding glycoprotein heterodimer of the spermadhesin family built by a CUB domain architecture. J Mol Biol (1997) 0.96
Plasmin-induced platelet aggregation and platelet release reaction. Effects on hemostasis. J Clin Invest (1973) 0.95
Isolation and biochemical characterization of the alpha- and beta-subunits of glycoprotein IIb of human platelet plasma membrane. Biochem J (1986) 0.95
Isolation and biochemical characterization of heparin-binding proteins from boar seminal plasma: a dual role for spermadhesins in fertilization. Mol Reprod Dev (1993) 0.94
Advanced ovulation in gilts by the intrauterine application of a low molecular mass pronase-sensitive fraction of boar seminal plasma. J Reprod Fertil (1995) 0.93
Interaction of disintegrins with the alpha IIb beta 3 receptor on resting and activated human platelets. Biochem J (1994) 0.93
Molecular cloning and characterization of P47, a novel boar sperm-associated zona pellucida-binding protein homologous to a family of mammalian secretory proteins. Biol Reprod (1998) 0.93
Analysis of xysA, a gene from Streptomyces halstedii JM8 that encodes a 45-kilodalton modular xylanase, Xys1. Appl Environ Microbiol (1997) 0.93
High molecular weight kininogen inhibits fibrinogen binding to cytoadhesins of neutrophils and platelets. J Cell Biol (1989) 0.92
ATP sulfurylases from sulfate-reducing bacteria of the genus Desulfovibrio. A novel metalloprotein containing cobalt and zinc. Biochemistry (1998) 0.92
The release of platelet factor 4 during platelet aggregation and the possible significance of this reaction in hemostasis. Experientia (1968) 0.92
Effects of the disintegrin eristostatin on individual steps of hematogenous metastasis. Exp Cell Res (1995) 0.92
Immunological characterization of eristostatin and echistatin binding sites on alpha IIb beta 3 and alpha V beta 3 integrins. Biochem J (1996) 0.92
Platelet aggregation and exposure of fibrinogen receptors by prostaglandin endoperoxide analogues. Blood (1983) 0.91
Structural and functional characterization of EMF10, a heterodimeric disintegrin from Eristocophis macmahoni venom that selectively inhibits alpha 5 beta 1 integrin. Biochemistry (1999) 0.91
Platelet interaction with fibrinogen and fibrin: comparison of the interaction of platelets with that of fibroblasts, leukocytes, and erythrocytes. Ann N Y Acad Sci (1972) 0.91
Inhibition of dog fibrinolytic system in experimental tubular necrosis of kidney. Experientia (1964) 0.90
Crystal structure of native and Cd/Cd-substituted Dioclea guianensis seed lectin. A novel manganese-binding site and structural basis of dimer-tetramer association. J Mol Biol (2001) 0.90
Inhibition of platelet hemostatic plug formation by trigramin, a novel RGD-peptide. Am J Physiol (1989) 0.90
Inhibition of fibrinogen receptor-mediated platelet aggregation by heterologous anti-human platelet membrane antibody. Significance of an Mr = 66,000 protein derived from glycoprotein IIIa. J Biol Chem (1983) 0.90
Pathological implications of cell aging in vitro. Fed Proc (1975) 0.89
Effect of heparin on the in vivo release and clearance of human platelet factor 4. Blood (1983) 0.89
Loss of platelet fibrinogen receptors during clinical cardiopulmonary bypass. J Thorac Cardiovasc Surg (1989) 0.89
Participation of soluble fibrin monomer complexes and platelet factor 4 in the generalized Shwartzman reaction. Thromb Diath Haemorrh (1968) 0.88
The disintegrin eristostatin interferes with integrin alpha 4 beta 1 function and with experimental metastasis of human melanoma cells. Exp Cell Res (1998) 0.88
Adhesion of fibroblasts to polymerizing fibrin and retraction of fibrin induced by fibroblasts. Proc Soc Exp Biol Med (1972) 0.88
Extracellular matrix molecules regulate endothelial cell migration stimulated by lysophosphatidic acid. J Thromb Haemost (2004) 0.88
Disintegrin interaction with alpha V beta 3 integrin on human umbilical vein endothelial cells: expression of ligand-induced binding site on beta 3 subunit. Exp Cell Res (1996) 0.88